immune system
N |
• normal thymocyte development and composition of peripheral immune cells under steady-state conditions
• normal TGFB and IL10 levels in lung after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal cytokine and chemokine production in lung and spleen 3 days after systemic administration of poly I:C
|
• fewer virus-specific T cells in bronchioalveolar lavage (BAL) sample 5 and 6 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal virus-specific T cell number in BAL sample 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in mediastinal lymph node (MLN) after i.n. inoculation with 10<3> pfu of influenza strain X31
|
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• more virus-specific T cells in spleen 5 and 6 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 2 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in spleen 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in mediastinal lymph node (MLN) after i.n. inoculation with 10<3> pfu of influenza strain X31
|
• higher percentage of CD62L
and lower percentage of CD62L
• normal 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
|
• increased CXCL1, CXCL2 and CCL2 levels in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
|
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
|
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
|
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
|
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
|
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
|
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
|
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
|
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 20 pfu of H1N1 influenza strain A/Puerto Rico/8/34 (PR8)
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
|
hematopoietic system
• fewer virus-specific T cells in bronchioalveolar lavage (BAL) sample 5 and 6 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal virus-specific T cell number in BAL sample 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in mediastinal lymph node (MLN) after i.n. inoculation with 10<3> pfu of influenza strain X31
|
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• more virus-specific T cells in spleen 5 and 6 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 2 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in spleen 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in mediastinal lymph node (MLN) after i.n. inoculation with 10<3> pfu of influenza strain X31
|
• higher percentage of CD62L
and lower percentage of CD62L
• normal 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
|
growth/size/body
N |
• no obvious phenotype
|
embryo
N |
• viable
|
mortality/aging
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 20 pfu of H1N1 influenza strain A/Puerto Rico/8/34 (PR8)
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
|
reproductive system
N |
• fertile
|